Sign inJoin waitlistJoin the waitlist

Melissa Mavers

Assistant Professor, Pediatric Oncologist, Washington University-St. Louis · Duke University Hospital

Credentials: · · · ·

History

Duke University Hospital
Present

Hematology and Medical Oncology
Stanford University
2014–2017
Internal Medicine
2011–2014
Saint Louis University School of Medicine
2007–2011

Research

Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance
Journal of Clinical Investigation · 2021 · 68 citations
The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages
European Journal of Immunology · 2009 · 63 citations
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
Frontiers in Immunology · 2017 · First of 3 authors · 59 citations

Robert Negrin
7 papers
Jeffery Bednarski
5 papers
RH
Robert Hayashi
5 papers
SS
Shalini Shenoy
5 papers
TP
Thomas Pfeiffer
5 papers
Harris Perlman
4 papers
Akshay Sharma
2 papers
Alice Bertaina
2 papers
Eric Ruderman
2 papers
GH
George Haines
2 papers
John DiPersio
2 papers
MS
Maulik Shah
2 papers

Grants

Immunosuppressive Human Invariant Natural Killer T Cells for Prevention of Graft-Versus-Host Disease
National Heart, Lung, and Blood Institute · K08
Contact PI · $832.7K · Washington University
2020–2025

Clinical trials

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
Site PI · Recruiting · Phase 1, Phase 2
Cartesian Therapeutics
2026–2028
Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML
Sub-investigator · Recruiting · Phase 1, Phase 2
Washington University School of Medicine
2024–2030
Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies
Sub-investigator · Recruiting · Phase 1
Washington University School of Medicine
2022–2029